GIDYL~~Our Approach,,Our revolutionary EndoBarrier® is a testament to the GI Dynamics mission. The first endoscopically inserted treatment for the management of type 2 diabetes and obesity. Both minimally invasive and completely reversible. EndoBarrier bridges the gap between pharmaceuticals and surgery by providing a safer and more effective way to control glucose and weight loss for individuals who are underserved by drugs and injections, but for whom surgery is not an option.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.